Skip to main content
Richard Markham, MD, Infectious Disease, Baltimore, MD

RichardBryanMarkhamMD

Infectious Disease Baltimore, MD

Joint Appointment in Medicine

Are you Dr. Markham?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 40 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    615 N Wolfe St
    Baltimore, MD 21205
    Phone+1 410-955-9601
    Fax+1 410-614-8263

Summary

  • Dr. Richard Markham, MD is an infectious disease specialist in Baltimore, Maryland. He is currently licensed to practice medicine in Maryland. He is affiliated with Johns Hopkins Hospital.

Education & Training

  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Internal Medicine, 1977 - 1979
  • Jacobi Medical Center/Albert Einstein College of Medicine
    Jacobi Medical Center/Albert Einstein College of MedicineResidency, Internal Medicine, 1973 - 1975
  • Albert Einstein College of Medicine
    Albert Einstein College of MedicineClass of 1972

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1976 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Infectious Disease

Publications & Presentations

PubMed

Grant Support

  • Use Of Clonal Genotyping To Predict Resistance Development In Art-Naive IDUNational Institute On Drug Abuse2008–2012
  • Effect Of Cocaine And LTR Polymorphism On HIV-1 PathogenesisNational Institute On Drug Abuse2008–2012
  • Training: Molecular &Cellular Bases Of Infectious DiseasesNational Institute Of Allergy And Infectious Diseases2010–2011
  • Roche 454 Genome Sequencer FlxNational Center For Research Resources2010
  • Development Of Transformed Lactobacilli As A MicrobicideNational Institute Of Allergy And Infectious Diseases2009–2010
  • Development Of A Malaria DNA Vaccine With Enchanced ImmunogenicityNational Institute Of Allergy And Infectious Diseases2008–2009
  • Anti-Icam-I Scfv From Lactobacilli As A MicrobicideNational Institute Of Allergy And Infectious Diseases2004–2007
  • Anti-Icam-1 Scfv From Lactobacilli As A MicrobicideNational Institute Of Allergy And Infectious Diseases2003–2004
  • Drug Abuse And Resistance To Antiretroviral TherapyNational Institute On Drug Abuse2000–2004
  • Acquired Immunodeficiency Syndrome ReviewNational Institute Of Allergy And Infectious Diseases2001–2002
  • Impact Of Recombination In HIV-1 On Intrahost EvolutionNational Institute Of General Medical Sciences1999–2002
  • HIV 1 Immune Activation And Pathogenesis In Drug UsersNational Institute On Drug Abuse1995–1998
  • Genetic Determinants Of HIV Infection Of IV Drug UsersNational Institute On Drug Abuse1995–1998
  • Model For AIDS TherapyNational Institute Of Allergy And Infectious Diseases1989–1993
  • Core--Scid-Hu MouseNational Institute Of Allergy And Infectious Diseases1989–1993
  • T Cell Immunity To Extracellular BacteriaNational Institute Of Allergy And Infectious Diseases1989–1991
  • T Cell Killing Of Extracellular BacteriaNational Institute Of Allergy And Infectious Diseases1985–1987